Lantheus Holdings, Inc.
Lantheus Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1956, the company has established itself as a leader in the development and commercialisation of innovative diagnostic and therapeutic products, particularly in the fields of oncology and cardiovascular imaging. Lantheus is renowned for its advanced imaging agents, including the widely used PET imaging agent, which aids in the detection and management of various cancers. The company’s commitment to enhancing patient care through precision medicine has positioned it favourably within the market. With a strong focus on research and development, Lantheus continues to achieve significant milestones, solidifying its reputation as a trusted partner in the healthcare community.
DitchCarbon Score
How does Lantheus Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lantheus Holdings, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lantheus Holdings, Inc.'s reported carbon emissions
Lantheus Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives related to climate commitments. The absence of emissions data suggests that the company may not have established a comprehensive framework for tracking its carbon footprint across Scope 1, 2, and 3 emissions. As of now, Lantheus has not disclosed any science-based targets or commitments through initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of information indicates that the company may still be in the early stages of developing its climate strategy or reporting practices. In the context of the broader industry, many companies are increasingly focusing on sustainability and carbon reduction, making it essential for Lantheus to consider establishing measurable targets and transparent reporting to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lantheus Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
